These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Double-blind study of four oral cholecystographic preparations. Parks RE Radiology; 1974 Sep; 112(3):525-8. PubMed ID: 4602064 [No Abstract] [Full Text] [Related]
25. Clinical comparison of locetamic acid (cholebrine) and ipodate sodium (Orgrafin). Neal RR; Harvey KG; Cantwell KG; Press HC AJR Am J Roentgenol; 1979 May; 132(5):735-6. PubMed ID: 155391 [TBL] [Abstract][Full Text] [Related]
26. [Recent triiodinated contrast media for oral cholecystocholangiography]. Sviridov NK; Popova ZP; Varfolomeeva VN Med Radiol (Mosk); 1985 Feb; 30(2):58-60. PubMed ID: 3155821 [No Abstract] [Full Text] [Related]
27. A new contrast agent for oral cholecystography: iopronic acid (Oravue). Pizzolato NF; Arcomano JP; Baum AE AJR Am J Roentgenol; 1978 May; 130(5):845-7. PubMed ID: 417581 [TBL] [Abstract][Full Text] [Related]
28. Hepatic excretion of cholecystopaques introduced into the canine jejunum. Menuck L; Amberg JR; Bates M Invest Radiol; 1977; 12(1):106-8. PubMed ID: 138663 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacology of oral cholecystography]. GaĆ³n D Acta Gastroenterol Latinoam; 1980; 10(3):231-41. PubMed ID: 7013405 [No Abstract] [Full Text] [Related]
30. An evaluation of oral cholecystography. Rosenbaum HD JAMA; 1974 Jul; 229(1):76-9. PubMed ID: 4406744 [No Abstract] [Full Text] [Related]
31. [Cholecysto-cholangiography. 2. Comparative study of various radiographic methods]. Nanbu M; Kobayashi N; Yamaguchi K; Namihisa T; Shirakabe H Rinsho Hoshasen; 1972 Jan; 17(1):38-45. PubMed ID: 4482038 [No Abstract] [Full Text] [Related]
32. [Problems related to the radiographic study of the biliary tract using oral or intravenous contrast media. Main side effects and biochemical changes induced by the administration of contrast media]. Limido G Minerva Dietol Gastroenterol; 1984; 30(1):9-15. PubMed ID: 6374500 [No Abstract] [Full Text] [Related]
33. Evaluation of the double contrast media technique for oral cholecystography. Palmer V; Gauli A Radiol Technol; 1970 Mar; 41(5):284-7. PubMed ID: 5416519 [No Abstract] [Full Text] [Related]
34. Pharmacologic properties of a new oral contrast medium for cholecystography. Rosati G; De Micheli P; Schiantarelli P Acta Radiol Diagn (Stockh); 1972 May; 12(3):335-46. PubMed ID: 5045427 [No Abstract] [Full Text] [Related]
35. Clinical trial of bilopaque (tyropanoate sodium) oral cholecystography. Evaluation of time for the optimal and peak opacification of the gallbladder. Han SY; Witten DM Radiology; 1974 Sep; 112(3):529-30. PubMed ID: 4843280 [No Abstract] [Full Text] [Related]
36. Oral cholecystography: osmotic activity of iopanoic glucuronide in bile. Mudge GH; Cooke WJ Johns Hopkins Med J; 1975 Aug; 137(2):65-8. PubMed ID: 1160206 [TBL] [Abstract][Full Text] [Related]
37. Double blind clinical comparison of two oral cholecystographic contrast media. Perez CA; Friedenberg MJ Mo Med; 1966 Jan; 63(1):46-9. PubMed ID: 5329730 [No Abstract] [Full Text] [Related]
38. Combined cholangiography and cholecystography using sodium iopanoate. Koehler RE; Goldberg HI Invest Radiol; 1977; 12(3):267-72. PubMed ID: 863631 [TBL] [Abstract][Full Text] [Related]
39. Factors in the intestinal absorption of oral cholecystopaques. Amberg JR; Thompson WM; Golberger L; Williamson S; Alexander R; Bates M Invest Radiol; 1980; 15(6 Suppl):S136-41. PubMed ID: 7203915 [TBL] [Abstract][Full Text] [Related]